$CRVW
CareView Communications Inc Stock $crvw

$crvw Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000199937124004190 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$2.203M	$1.767M	$9.685M
YoY Change	23.62%	-7.88%	22.57%
Cost Of Revenue	$843.3K	$740.0K	$2.746M
YoY Change	19.61%	101.55%	6.76%
Gross Profit	$1.360M	$1.027M	$6.938M
YoY Change	26.25%	-33.78%	30.2%
Gross Profit Margin	61.72%	58.12%	71.64%
Selling, General & Admin	$945.5K	$1.017M	$4.274M
YoY Change	9.15%	7.08%	3.58%
% of Gross Profit	69.52%	99.0%	61.59%
Research & Development	$527.5K	$847.0K	$2.503M
YoY Change	1.71%	189.85%	52.69%
% of Gross Profit	38.79%	82.48%	36.07%
Depreciation & Amortization	$65.83K	$62.01K	$412.0K
YoY Change	-35.78%	-54.91%	-17.85%
% of Gross Profit	4.84%	6.04%	5.94%
Operating Expenses	$1.593M	$1.975M	$7.627M
YoY Change	-30.68%	20.99%	-16.85%
Operating Profit	-$233.4K	-$948.1K	-$688.3K
YoY Change	-54.8%	1062.16%	-45.82%
Interest Expense	-$788.8K	-$668.2K	-$3.189M
YoY Change	-194.89%	-40.58%	-150.93%
% of Operating Profit
Other Income/Expense, Net			$0.00
YoY Change			-100.0%
Pretax Income	-$1.022M	-$1.616M	-$3.878M
YoY Change	-24.1%	-670.37%	-35.83%
Income Tax	$0.00	$74.52K	$74.52K
% Of Pretax Income
Net Earnings	-$1.022M	-$1.691M	-$3.952M
YoY Change	-24.1%	-696.67%	-34.59%
Net Earnings / Revenue	-46.4%	-95.69%	-40.81%
Basic Earnings Per Share			-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	583.9M shares	583.9M shares	448.5M shares
Diluted Shares Outstanding			448.5M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.250M	$1.146M	$1.146M
YoY Change	182.73%	120.29%	120.29%
Cash & Equivalents	$1.250M	$1.146M	$1.146M
Short-Term Investments
Other Short-Term Assets	$247.2K	$335.1K	$335.1K
YoY Change	225.59%	371.82%	371.82%
Inventory	$337.9K	$294.4K	$294.4K
Prepaid Expenses		$62.84K
Receivables	$1.215M	$1.168M	$1.168M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.049M	$2.943M	$2.943M
YoY Change	41.47%	59.88%	59.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$520.5K	$610.6K	$610.6K
YoY Change	-3.63%	-4.97%	-43.3%
Goodwill
YoY Change
Intangibles		$406.3K
YoY Change		-50.46%
Long-Term Investments
YoY Change
Other Assets	$288.9K	$302.0K	$302.0K
YoY Change	60.66%	-79.37%	44.05%
Total Long-Term Assets	$1.223M	$1.319M	$1.319M
YoY Change	-34.98%	-37.39%	-37.39%
TOTAL ASSETS
Total Short-Term Assets	$3.049M	$2.943M	$2.943M
Total Long-Term Assets	$1.223M	$1.319M	$1.319M
Total Assets	$4.273M	$4.262M	$4.262M
YoY Change	5.84%	7.97%	7.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$655.7K	$598.1K	$598.1K
YoY Change	-6.67%	-8.1%	-8.1%
Accrued Expenses	$17.67M	$17.10M	$17.10M
YoY Change	21.69%	24.08%	24.08%
Deferred Revenue
YoY Change
Short-Term Debt	$700.0K	$700.0K	$700.0K
YoY Change	-96.26%	0.0%	0.0%
Long-Term Debt Due	$20.00M	$20.00M	$20.00M
YoY Change	0.0%	-60.0%	-60.0%
Total Short-Term Liabilities	$41.30M	$40.21M	$40.21M
YoY Change	-25.57%	-39.15%	-39.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$201.0K	$318.0K	$318.0K
YoY Change	913.2%	1254.33%	-3.26%
Total Long-Term Liabilities	$201.0K	$318.0K	$318.0K
YoY Change	-29.77%	-97.81%	-97.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$41.30M	$40.21M	$40.21M
Total Long-Term Liabilities	$201.0K	$318.0K	$318.0K
Total Liabilities	$41.50M	$40.52M	$40.52M
YoY Change	-25.6%	-49.73%	-49.73%
SHAREHOLDERS EQUITY
Retained Earnings		-$207.9M
YoY Change		1.94%
Common Stock		$171.6M
YoY Change		34.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$37.23M	-$36.26M	-$36.26M
YoY Change
Total Liabilities & Shareholders Equity	$4.273M	$4.262M	$4.262M
YoY Change	5.84%	7.97%	7.97%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.022M	-$1.691M	-$3.952M
YoY Change	-24.1%	-696.67%	-34.59%
Depreciation, Depletion And Amortization	$65.83K	$62.01K	$412.0K
YoY Change	-35.78%	-54.91%	-17.85%
Cash From Operating Activities	$129.5K	$533.6K	$703.6K
YoY Change	-273.71%	-709.91%	-290.12%
INVESTING ACTIVITIES
Capital Expenditures	$22.28K	$6.790K	$16.79K
YoY Change		-111.65%	223.57%
Acquisitions
YoY Change
Other Investing Activities		-$45.68K	-$45.68K
YoY Change
Cash From Investing Activities	-$22.28K	-$52.47K	-$62.47K
YoY Change		-190.06%	1103.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.520K	-5.440K	-15.44K
YoY Change	-3.27%	-102.09%	-106.54%
NET CHANGE
Cash From Operating Activities	129.5K	533.6K	703.6K
Cash From Investing Activities	-22.28K	-52.47K	-62.47K
Cash From Financing Activities	-3.520K	-5.440K	-15.44K
Net Change In Cash	103.7K	475.7K	625.7K
YoY Change	-232.63%	105.64%	-549.94%
FREE CASH FLOW
Cash From Operating Activities	$129.5K	$533.6K	$703.6K
Capital Expenditures	$22.28K	$6.790K	$16.79K
Free Cash Flow	$107.2K	$526.8K	$686.8K
YoY Change	-243.83%	-1902.33%	-283.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001377149
CY2023	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	us-gaap	Senior Notes Current SeniorNotesCurrent		usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	crvw	Payments For Deferred Installation Costs PaymentsForDeferredInstallationCosts		usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities		usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt		usd
CY2023	crvw	Cancellation Of Accrued Interest CancellationOfAccruedInterest		usd
CY2023	crvw	Issuance Of Warrants For Debt Discount IssuanceOfWarrantsForDebtDiscount		usd
CY2022	crvw	Non Cash Debt To Equity Conversion NonCashDebtToEquityConversion		usd
CY2022	crvw	Additions To Deferred Costs AdditionsToDeferredCosts		usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent		usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable		usd
CY2020Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54090
CY2023	dei	Entity Registrant Name EntityRegistrantName	CAREVIEW COMMUNICATIONS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4659068
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	405 State Highway 121
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite B-240
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Lewisville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75067
CY2023	dei	City Area Code CityAreaCode	(972)
CY2023	dei	Local Phone Number LocalPhoneNumber	943-6050
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	CRVW
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	35032845	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	583880748	shares
CY2023	dei	Auditor Firm AuditorFirmId	89
CY2023	dei	Auditor Name AuditorName	Rosenberg Rich Baker Berman, P.A.
CY2023	dei	Auditor Location AuditorLocation	Somerset, New Jersey
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1145871	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	420166	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1167934	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	948328	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	294435	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	301446	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	335091	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71020	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2943331	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1840960	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	317626	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	642559	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	406301	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	820106	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	292990	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	434330	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	302010	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	209649	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1001301	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1464085	usd
CY2023Q4	us-gaap	Assets Assets	4262258	usd
CY2022Q4	us-gaap	Assets Assets	3947604	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	598095	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	650796	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	20000000	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	20000000	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	700000	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	700000	usd
CY2022Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	30000000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1752061	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	890631	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	16479139	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	13270638	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	188184	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175520	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	489497	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	392008	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	40206976	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	66079593	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	12369168	usd
CY2022Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	1830832	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	139099	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	305259	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	178907	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23481	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	318006	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14528740	usd
CY2023Q4	us-gaap	Liabilities Liabilities	40524982	usd
CY2022Q4	us-gaap	Liabilities Liabilities	80608333	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	583880748	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	583880748	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	583881	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	141881	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	171038349	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	127130055	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-207884954	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203932665	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-36262724	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-76660729	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4262258	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3947604	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9684618	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7901341	usd
CY2023	us-gaap	Equipment Expense EquipmentExpense	407309	usd
CY2022	us-gaap	Equipment Expense EquipmentExpense	245532	usd
CY2023	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	2746302	usd
CY2022	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	2477123	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3239940	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3101172	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1033608	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	791604	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2502924	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1967404	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	442837	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	588928	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10372920	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9171763	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-688302	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1270422	usd
CY2023	us-gaap	Interest Expense InterestExpense	3208500	usd
CY2022	us-gaap	Interest Expense InterestExpense	6262051	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	19031	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	497	usd
CY2022	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	1489357	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3189469	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4772197	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3877771	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6042619	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74518	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-3952289	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6042619	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	448488967	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	448488967	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141880748	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141880748	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-112698298	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	240000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	230112	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	41360076	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6042619	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-76660729	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	150294	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	44200000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-3952289	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-36262724	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-3952289	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6042619	usd
CY2023	us-gaap	Depreciation Depreciation	334676	usd
CY2022	us-gaap	Depreciation Depreciation	501521	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	77330	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51967	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	334358	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	crvw	Amortization Of Installation Costs AmortizationOfInstallationCosts	47224	usd
CY2022	crvw	Amortization Of Installation Costs AmortizationOfInstallationCosts	51833	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1480626	usd
CY2023	crvw	Noncash Lease Expense NoncashLeaseExpense	141340	usd
CY2022	crvw	Noncash Lease Expense NoncashLeaseExpense	120820	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	4781424	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	150294	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	230112	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1489357	usd
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-7048	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-38325	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	219607	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15128	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7011	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47770	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	264070	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-164501	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-50584	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	236463	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3208500	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-114290	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	97489	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-232374	usd
CY2023	us-gaap	Increase Decrease In Regulatory Clause Revenue IncreaseDecreaseInRegulatoryClauseRevenue	1032296	usd
CY2022	us-gaap	Increase Decrease In Regulatory Clause Revenue IncreaseDecreaseInRegulatoryClauseRevenue	-93037	usd
CY2023	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	93906	usd
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-38080	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-153496	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-126724	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	703614	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-370087	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16791	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	250000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	13786	usd
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	15439	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5189	usd
CY2023	crvw	Payments For Deferred Installation Costs PaymentsForDeferredInstallationCosts	45679	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-62470	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5189	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15439	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	236214	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	625705	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-139062	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520166	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	659228	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1145871	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520166	usd
CY2022	crvw	Cancellation Of Accrued Interest CancellationOfAccruedInterest	47395000	usd
CY2022	crvw	Issuance Of Warrants For Debt Discount IssuanceOfWarrantsForDebtDiscount	240000	usd
CY2023	crvw	Non Cash Debt To Equity Conversion NonCashDebtToEquityConversion	44200000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	794000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2022Q4	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2023	us-gaap	Indefinite Lived Intangible Assets Written Off Related To Sale Of Business Unit IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit	334359	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9684618	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7901341	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	869485	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	752526	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1922925	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1922925	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	33461	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	68901	usd
CY2023	crvw	Additions To Deferred Costs AdditionsToDeferredCosts	45679	usd
CY2023	crvw	Transfer To Expense TransferToExpense	30831	usd
CY2022	crvw	Transfer To Expense TransferToExpense	35440	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	48309	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	33461	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	526425	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1074500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.05
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44178422	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	488511922	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44178422	shares
CY2023	us-gaap	Advertising Expense AdvertisingExpense	335000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	111000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zQAER4Vdug34" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline"><span id="xdx_860_z77bscdIlka1">Concentration of Credit Risks and Customer Data</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In 2023, our revenue was driven significantly by two customers, accounting for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zRVOExv9M0x4">17</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z7p7VDGDie3b">13</span>% respectively, while in 2022, a single customer contributed <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zb1A0H17aNx6">12</span>% to our revenue. As of December 31, 2023, we had one customer that accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231230__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAJ1BOnNiAw6">21</span>% of our accounts receivable.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z7VJT7n3Wr68" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zOkRtRG56BBc">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Our financial statements have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make significant estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosure of contingent assets and liabilities. We evaluate our estimates, including those related to contingencies, on an ongoing basis. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p>
CY2023Q4	crvw	Working Capital WorkingCapital	-37122344	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	583880748	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	583880748	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141880748	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141880748	shares
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2500000	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.10
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	40817477	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
CY2023	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Begining SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermBegining	P5Y9M18D
CY2023	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P9Y6M
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3063000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.49
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	345000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.07
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	38483977	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.09
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	314925	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	37178810	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.09
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	314925	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	150294	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	230112	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	68391	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	24114281	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-7601775	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	43401395	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19261098	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	864050	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	1522314	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	734667	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	342341	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-10922	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	14723	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3991	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	103619	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	52601	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	67600	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	649695	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	45695478	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21311696	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	45695478	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21311696	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	294435	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	301446	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	294435	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	301446	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	180267	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	62843	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	71020	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	91981	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	335091	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71020	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9926453	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13424954	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9608827	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12782395	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	317626	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	642559	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	334676	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	501521	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	899729	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	493428	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	406301	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1299746	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	479640	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	820106	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	79447	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	51967	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	334358	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q4	crvw	Other Assets Noncurrent Gross OtherAssetsNoncurrentGross	2133064	usd
CY2023Q4	crvw	Other Assets Accumulated Amortization OtherAssetsAccumulatedAmortization	1831054	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	302010	usd
CY2022Q4	crvw	Other Assets Noncurrent Gross OtherAssetsNoncurrentGross	1812137	usd
CY2022Q4	crvw	Other Assets Accumulated Amortization OtherAssetsAccumulatedAmortization	1602488	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	209649	usd
CY2023Q4	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2022Q4	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	164566	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	154776	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	49528	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	139041	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	220601	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	43389	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	489497	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	392008	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	20700000	usd
CY2022Q4	crvw	Cancellation Agreement Notes Value CancellationAgreementNotesValue	87376000	usd
CY2022Q4	crvw	Cancellation Agreement Number Of Warrants CancellationAgreementNumberOfWarrants	14204000	shares
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P20M
CY2020Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-08-31
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.148	pure
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	295223	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	279005	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	292990	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	292990	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	188184	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	139099	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	327283	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	221069	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	150680	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	371749	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	44466	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	327283	usd
CY2023	crvw	Operating Cash Flows For Operating Leases OperatingCashFlowsForOperatingLeases	306803	usd

Files In Submission

Name	View Source	Status
0001999371-24-004190-index-headers.html	Edgar Link	pending
0001999371-24-004190-index.html	Edgar Link	pending
0001999371-24-004190.txt	Edgar Link	pending
0001999371-24-004190-xbrl.zip	Edgar Link	pending
crvw-10k_123123.htm	Edgar Link	pending
crvw-20231231.xsd	Edgar Link	pending
ex21.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
crvw-20231231_cal.xml	Edgar Link	unprocessable
crvw-20231231_def.xml	Edgar Link	unprocessable
crvw-20231231_lab.xml	Edgar Link	unprocessable
crvw-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crvw-10k_123123_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRVW
CareView Communications Inc Stock $crvw

2024 Q1 Form 10-K Financial Statement

#000199937124004190 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW CareView Communications Inc Stock $crvw

2024 Q1 Form 10-K Financial Statement

#000199937124004190 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW
CareView Communications Inc Stock $crvw